Recombinant polymeric IgG: an approach to engineering more potent antibodies.
about
Molecular engineering and plant expression of an immunoglobulin heavy chain scaffold for delivery of a dengue vaccine candidateTransferrin-antibody fusion proteins are effective in brain targetingHomogeneous immunoconjugates for boron neutron-capture therapy: design, synthesis, and preliminary characterization.Homodimerization of tumor-reactive monoclonal antibodies markedly increases their ability to induce growth arrest or apoptosis of tumor cells.A comparison of anti-HER2 IgA and IgG1 in vivo efficacy is facilitated by high N-glycan sialylation of the IgA.Antibody-interleukin 2 fusion proteins: a new approach to cancer therapy.Structural requirements for polymeric immunoglobulin assembly and association with J chain.Structure and function of several anti-dansyl chimeric antibodies formed by domain interchanges between human IgM and mouse IgG2b.Design and production of novel tetravalent bispecific antibodies.Multivalent Fcγ-receptor engagement by a hexameric Fc-fusion protein triggers Fcγ-receptor internalisation and modulation of Fcγ-receptor functions.A peptide extension dictates IgM assembly.Enhanced opsonisation of Rhesus D-positive human red blood cells by recombinant polymeric immunoglobulin G anti-G antibodies.Overexpression of cryoglobulin-like single-chain antibody induces morular cell phenotype via liquid-liquid phase separation in the secretory pathway organelles.Structural requirements for incorporation of J chain into human IgM and IgA.Engineered hexavalent Fc proteins with enhanced Fc-gamma receptor avidity provide insights into immune-complex interactions
P2860
Q29587283-259A589A-C553-4BA5-81FE-8E14116819DBQ34506062-7D54C90D-E5FE-46AA-8676-C5A1F8F507A3Q36645847-AC6E1246-C281-4CFD-A126-62F389E911B6Q36659424-2D896253-1E44-4750-99D6-95EDD73B8134Q37138274-9149B523-82FF-48CE-B9C1-170017D7CAEEQ41055870-A2188FF7-5F29-41C1-B193-B1C57057A351Q41701999-A6061D69-16A5-4F5D-98B0-03980EA34DA9Q45974418-2F7B6773-B28F-4876-AE2E-7FA0526757BAQ46541575-7EEA4DAC-DE49-42B2-8BDF-790BE6A20E92Q47148202-25DDDC4F-65D7-4DDD-BF6D-8E9B116B1967Q47705372-3F98016D-C580-4EDD-8121-3048DA2D5AA3Q50203194-86369D9A-875C-47FB-B991-1A27E2E73750Q52660613-0AFF3565-F91C-4B98-B5C3-A8FF1BB4E498Q55033512-6822FCCA-FC21-41F8-891C-E2A2AB5AFB73Q57074754-2CF1801C-B9E9-4F75-833A-747B09E186AA
P2860
Recombinant polymeric IgG: an approach to engineering more potent antibodies.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Recombinant polymeric IgG: an approach to engineering more potent antibodies.
@en
Recombinant polymeric IgG: an approach to engineering more potent antibodies.
@nl
type
label
Recombinant polymeric IgG: an approach to engineering more potent antibodies.
@en
Recombinant polymeric IgG: an approach to engineering more potent antibodies.
@nl
prefLabel
Recombinant polymeric IgG: an approach to engineering more potent antibodies.
@en
Recombinant polymeric IgG: an approach to engineering more potent antibodies.
@nl
P356
P1433
P1476
Recombinant polymeric IgG: an approach to engineering more potent antibodies.
@en
P2093
P2860
P2888
P304
P356
10.1038/NBT0794-683
P577
1994-07-01T00:00:00Z
P5875
P6179
1038507586